REMEDI Inc. (KOSDAQ:387690)
South Korea · Delayed Price · Currency is KRW 17,550
-60 (-0.34%)
At close: Sep 9, 2026
REMEDI Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| 22,771 | 14,628 | 13,441 | 6,918 | |
Revenue Growth | - | 8.83% | 94.30% | - |
Cost of Revenue | 9,045 | 6,049 | 5,738 | 3,097 |
Gross Profit | 13,725 | 8,579 | 7,704 | 3,821 |
Selling, General & Admin | 4,568 | 3,974 | 4,566 | 3,131 |
Research & Development | 1,294 | 1,789 | 1,554 | 2,142 |
Amortization of Goodwill & Intangibles | 34.48 | 54.28 | 58.1 | 53.89 |
Operating Expenses | 5,852 | 5,829 | 6,760 | 6,140 |
Operating Income | 7,874 | 2,750 | 943.97 | -2,319 |
Interest Expense | - | - | - | -339.29 |
Interest & Investment Income | 56.49 | 43 | 68.23 | 19.73 |
Currency Exchange Gain (Loss) | 77.19 | -81.08 | 155.41 | -6.67 |
Other Non Operating Income (Expenses) | -254.82 | -294.73 | -399.49 | -185.55 |
EBT Excluding Unusual Items | 7,753 | 2,417 | 768.12 | -2,831 |
Gain (Loss) on Sale of Assets | - | - | - | 14.63 |
Asset Writedown | - | - | - | -843.31 |
Other Unusual Items | - | - | -26.76 | - |
Pretax Income | 7,753 | 2,417 | 741.36 | -3,659 |
Income Tax Expense | -1,411 | -2,670 | - | - |
Earnings From Continuing Operations | 9,164 | 5,087 | 741.36 | -3,659 |
Minority Interest in Earnings | -142.87 | -121.29 | 165.1 | - |
Net Income | 9,021 | 4,965 | 906.46 | -3,659 |
Net Income to Common | 9,021 | 4,965 | 906.46 | -3,659 |
Net Income Growth | - | 447.79% | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 |
Shares Change | - | - | - | - |
EPS (Basic) | 1409.19 | 777.10 | 141.86 | -572.67 |
EPS (Diluted) | 1409.09 | 777.00 | 141.86 | -573.00 |
EPS Growth | - | 447.72% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 1,429 | -2,978 | 2,276 | -5,852 |
Free Cash Flow Per Share | 223.16 | -466.06 | 356.13 | -915.89 |
Gross Margin | 60.28% | 58.65% | 57.31% | 55.23% |
Operating Margin | 34.58% | 18.80% | 7.02% | -33.52% |
Profit Margin | 39.62% | 33.95% | 6.74% | -52.90% |
Free Cash Flow Margin | 6.27% | -20.36% | 16.93% | -84.60% |
EBITDA | 8,691 | 3,556 | 1,749 | -1,561 |
EBITDA Margin | 38.17% | 24.31% | 13.01% | -22.56% |
D&A For EBITDA | 817.33 | 806.1 | 804.63 | 758.01 |
EBIT | 7,874 | 2,750 | 943.97 | -2,319 |
EBIT Margin | 34.58% | 18.80% | 7.02% | -33.52% |
Advertising Expenses | - | 5.12 | 20.02 | 9.66 |